Jennison Associates LLC Arcutis Biotherapeutics, Inc. Transaction History
Jennison Associates LLC
- $141 Billion
- Q1 2025
A detailed history of Jennison Associates LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 11,360,875 shares of ARQT stock, worth $163 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
11,360,875
Previous 12,339,792
7.93%
Holding current value
$163 Million
Previous $172 Million
3.37%
% of portfolio
0.13%
Previous 0.11%
Shares
12 transactions
Others Institutions Holding ARQT
# of Institutions
251Shares Held
126MCall Options Held
605KPut Options Held
170K-
Suvretta Capital Management, LLC New York, NY11.4MShares$164 Million7.82% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$157 Million4.91% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$126 Million8.65% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$124 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$97.8 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $863M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...